FY2027 EPS Estimates for Senseonics Raised by HC Wainwright

Senseonics Holdings, Inc. (NYSE:SENS - Free Report) - Equities research analysts at HC Wainwright upped their FY2027 earnings per share estimates for Senseonics in a report released on Monday, July 14th. HC Wainwright analyst S. Lee now anticipates that the company will post earnings per share of ($0.02) for the year, up from their prior estimate of ($0.03). HC Wainwright currently has a "Buy" rating and a $1.40 price target on the stock. The consensus estimate for Senseonics' current full-year earnings is ($0.14) per share. HC Wainwright also issued estimates for Senseonics' FY2029 earnings at $0.03 EPS.

A number of other analysts also recently weighed in on the stock. Wall Street Zen raised shares of Senseonics to a "sell" rating in a report on Monday, May 12th. Mizuho initiated coverage on Senseonics in a research note on Thursday, April 10th. They set an "outperform" rating and a $2.00 target price for the company. Finally, TD Cowen initiated coverage on Senseonics in a report on Tuesday. They issued a "buy" rating and a $1.25 target price on the stock.

Senseonics Price Performance

SENS stock traded up $0.03 during mid-day trading on Wednesday, hitting $0.56. The stock had a trading volume of 18,012,103 shares, compared to its average volume of 7,295,972. The firm has a fifty day simple moving average of $0.52 and a 200 day simple moving average of $0.68. The firm has a market capitalization of $368.98 million, a P/E ratio of -4.33 and a beta of 0.92. The company has a current ratio of 2.47, a quick ratio of 2.38 and a debt-to-equity ratio of 59.17. Senseonics has a 52 week low of $0.25 and a 52 week high of $1.40.

Institutional Investors Weigh In On Senseonics

A number of hedge funds have recently made changes to their positions in SENS. Raymond James Financial Inc. acquired a new stake in shares of Senseonics during the 4th quarter valued at $26,000. IFP Advisors Inc boosted its stake in shares of Senseonics by 120.9% during the first quarter. IFP Advisors Inc now owns 47,500 shares of the company's stock valued at $31,000 after purchasing an additional 26,000 shares in the last quarter. CTC Alternative Strategies Ltd. acquired a new stake in shares of Senseonics during the first quarter valued at about $31,000. HighTower Advisors LLC bought a new stake in shares of Senseonics during the fourth quarter worth about $32,000. Finally, Two Sigma Investments LP acquired a new position in shares of Senseonics in the fourth quarter valued at approximately $36,000. 12.36% of the stock is currently owned by institutional investors and hedge funds.

About Senseonics

Senseonics Holdings, Inc, a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management.